US › Healthcare

Genenta Science SpA ADR (GNTA)

US · Healthcare · Biotechnology

$1.27-9.93%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit
$-2.7M
Profit YoY
+44.1%
EPS
$-0.20
EPS estimate
$0.00

Key statistics

Market cap
$71.8M
Forward P/E
0.0
P/B
2.90
Book value
$1.08
EPS (TTM)
$-0.38
52-week high
$6.20
52-week low
$0.55
50-day MA
$1.56
200-day MA
$1.42
Beta
0.75

Analyst view

Analysts rate Genenta Science SpA ADR a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $6.98.

Shareholding

Insiders
42.47%
Institutions
7.13%

Largest institutional holders

FundStake
Eurizon Capital SGR SpA0.75%
Allianz SE0.49%
AlTi Global Inc0.42%
SmartHarvest Portfolios, LLC0.28%
Independent Advisor Alliance0.08%
XTX Topco Ltd0.05%
Morgan Stanley - Brokerage Accounts0.03%
Simplicity Wealth,LLC0.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Genenta Science SpA ADR — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.